test2

Published: | Updated:
Simulmedia × Merck

Reach More Merck Patients Where They Watch

Your patients are watching TV. Are you reaching them?

Merck

The Challenge

Linear TV campaign in June 2025

Ad Spend

$7.1M

Missed Opportunity

54%

of target patients NOT reached

Only 46.1% reach rate = 37.3M patients at $191 per 1,000

You missed 54% of your target audience in June 2025. More than half of the people who could benefit from the brand's message never saw it — patients who are reachable on TV but remained untouched by your campaign.

These are the viewers within Merck's target audience that they're missing the opportunity to reach and turn into future consumers, patients, or advocates. In healthcare, every missed impression is more than a lost marketing opportunity — it's a missed chance to inform, support, and bring hope to someone who truly needs your brand.

We know your patients are watching TV.

However, they are not being reached.

80.9M strategic audience on TV Merck TV Viewers reached in June 2025 only 37.3M reached (46%)

Reaching 37.3 million viewers is meaningful—but it's only half the story. The dark purple circle represents your target audience, who is reachable on linear TV (80.9M). The lighter purple circle shows Merck's national linear TV campaign in June 2025, based on Nielsen Ad Intel data, which reached just a portion of that audience. The remaining viewers—people who fit your ideal profile but never saw your message—represent untapped potential. They're watching, engaging, and making decisions elsewhere. Using a data-driven approach with TV ensures your campaign reaches its full potential—without leaving millions of valuable prospects unseen.

Your Competition Isn't Reaching Patients Either

Opdivo Qvantig also struggles with patient reach

Opdivo

Opdivo Qvantig Campaign

Target Patient Audience Opdivo Qvantig TV Viewers reached only 50% reached

50% unreached = Missed patient opportunities

Your competitors aren't reaching them either—they're similarly leaving half of your target audience unserved. Even industry peers are struggling to close the reach gap. The dark blue circle represents your target audience reachable on TV, while the lighter blue circle shows your competitor, Opdivo's, national linear TV campaign in June 2025 (via Nielsen Ad Intel), which reached only about half of that audience. Staying within traditional TV boundaries means sharing the same limitations as your competitors. When everyone fights for the same audience, those who expand their reach first gain the advantage—because every unreached viewer today could be tomorrow's loyal customer.

Maximize Your Patient Reach with TV+

TV+ dramatically expands your reach beyond current campaigns

TV+ Optimization Solution

TV+ Maximum Reach Potential Merck Current Patient Reach June 2025 +90% more patients at the same budget

Current reach: 46.1% (37.3M patients at $191/1K)

With TV+, you can reach up to 90% more of your target audience—without increasing your spend. That's the power of a data-driven approach to television. By identifying undervalued pockets of your audience that traditional media buying overlooks, TV+ minimizes waste and expands your impact. Every additional viewer strengthens brand awareness and drives greater ROI. With TV+, reach and efficiency are no longer at odds—they work together to ensure every dollar works smarter and every impression truly counts.

Limited Time Offer

Ready to Reach More Patients?

See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.

📊

Data-Driven Insights

🎯

Precision Targeting

💰

Budget Optimization

📺

Cross-Channel Reach

Let Simulmedia help you reach your audience

Get started with TV+ today

🔒 Your information is secure. We respect your privacy.

Data provided by Nielsen AdIntel as of June 2025